Posted in | News | Business | Materials Analysis

Agilent Technologies Enters Acquisition Deal for Assets of ABC Instrumentación Analítica

Agilent Technologies Inc. and ABC Instrumentación Analítica today announced that they have signed a definitive agreement for Agilent to acquire assets from ABCIA. Privately held ABCIA, based in Mexico City, is a leading distributor of analytical solutions, including Agilent's chemical analysis and life science products.

The acquisition is expected to be completed on Oct. 1, subject to customary closing conditions. Financial details were not disclosed.

Once the acquisition is final, former ABCIA customers in Mexico can look forward to an integrated sales and service portfolio directly from Agilent.

ABCIA was established in 1986 as a distributor of Hewlett-Packard Company's analytical solutions. ABCIA became an Agilent distributor when HP spun off Agilent in 1999. ABCIA provides sales, application support and customer training for Agilent products such as gas and liquid chromatographs, mass spectrometers, atomic and molecular spectroscopy systems, and bioanalyzers.

"Agilent and ABCIA have had a strong partnership for more than two decades," said Sylvia Escobar, vice president in charge of field operations for Agilent's chemical analysis business in the Americas. "As a unified team, we will provide a better customer experience by streamlining processes and delivering top-tier service in a consistent way. This acquisition also supports Agilent's aim to expand in the growing Mexican analytical market."

"We have worked successfully with Agilent for many years, and see this acquisition as a natural fit for both parties," said César Espinoza, CEO and founder of ABCIA. "We are pleased with the acquisition as it provides the opportunity to further enhance our long partnership with Agilent and solidify the brand's presence in the expanding Mexican market. The unification of our teams also provides our employees with a major opportunity for further professional development while ensuring that our clients will receive even better service."

About 30 ABCIA employees are expected to transfer to Agilent when the acquisition is final.

About ABC Instrumentación Analítica

ABCIA is a market-leading company in the commercialization of both chemical analysis instruments and life science solutions in Mexico. With a consolidated network of offices in Mexico City, Guadalajara, Querétaro and Coatzacoalcos, the company has provided its customers with the best instruments, consumables and training for 26 years. ABCIA's long-standing reputation as a leading company in the field has allowed the company to build close collaborative relationships with its customers and provide them with the means to ensure the success of their particular endeavors in the analytical field.

For more information, visit www.abcia.com.mx.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Agilent Technologies, Inc.. (2019, February 09). Agilent Technologies Enters Acquisition Deal for Assets of ABC Instrumentación Analítica. AZoM. Retrieved on November 21, 2024 from https://www.azom.com/news.aspx?newsID=38135.

  • MLA

    Agilent Technologies, Inc.. "Agilent Technologies Enters Acquisition Deal for Assets of ABC Instrumentación Analítica". AZoM. 21 November 2024. <https://www.azom.com/news.aspx?newsID=38135>.

  • Chicago

    Agilent Technologies, Inc.. "Agilent Technologies Enters Acquisition Deal for Assets of ABC Instrumentación Analítica". AZoM. https://www.azom.com/news.aspx?newsID=38135. (accessed November 21, 2024).

  • Harvard

    Agilent Technologies, Inc.. 2019. Agilent Technologies Enters Acquisition Deal for Assets of ABC Instrumentación Analítica. AZoM, viewed 21 November 2024, https://www.azom.com/news.aspx?newsID=38135.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.